Literature DB >> 21643625

Proteolysis-inducing factor core peptide mediates dermcidin-induced proliferation of hepatic cells through multiple signalling networks.

Alastair G Lowrie1, Paul Dickinson, Nicholas Wheelhouse, Grant D Stewart, Alan J Ross, Thorsten Forster, James A Ross.   

Abstract

Dermcidin is a candidate oncogene capable of increasing the number of cultured neuronal, breast cancer and prostate cancer cells and improving the survival of hepatic cells. The dermcidin gene encodes the proteolysis-inducing factor core peptide (PIF-CP) and the skin antimicrobial peptide DCD-1. The peptide responsible for inducing proliferation of cells and the mechanisms involved are unknown. In this study, we confirmed a proliferative effect of dermcidin overexpression of 20% (p<0.02) in the HuH7 human hepatic cell line. Proliferation was abrogated by prevention of PIF-CP translation or inactivation of its calcineurin-like phosphatase domain by site-directed mutagenesis. Prevention of DCD-1 translation had no effect. Treatment of cells with a 30 amino acid synthetic PIF-CP induced an analogous increase in proliferation of 14%. Microarray analysis of PIF-CP-treated cells revealed low but significant changes in 111 potential mediator genes. Pathway analysis revealed several gene networks involved in the cellular response to the peptide, one with VEGFB as a hub and two other networks converging on FOS and MYC. Quantitative PCR confirmed direct upregulation of VEGFB. These data reveal PIF-CP as the key mediator of dermcidin-induced proliferation and demonstrate induction of key oncogenic pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643625     DOI: 10.3892/ijo.2011.1064

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  Dermcidin expression is associated with disease progression and survival among breast cancer patients.

Authors:  Heather Ann Brauer; Monica D'Arcy; Tanya E Libby; Henry J Thompson; Yutaka Y Yasui; Nobuyuki Hamajima; Christopher I Li; Melissa A Troester; Paul D Lampe
Journal:  Breast Cancer Res Treat       Date:  2014-02-22       Impact factor: 4.872

2.  Seriniquinone, a selective anticancer agent, induces cell death by autophagocytosis, targeting the cancer-protective protein dermcidin.

Authors:  Lynnie Trzoss; Takashi Fukuda; Letícia V Costa-Lotufo; Paula Jimenez; James J La Clair; William Fenical
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-30       Impact factor: 11.205

3.  Effect of purified fractions from cell culture supernate of high-density pre-B acute lymphoblastic leukemia cells (ALL3) on the growth of ALL3 cells at low density.

Authors:  Sapan J Patel; Costel C Darie; Bayard D Clarkson
Journal:  Electrophoresis       Date:  2016-11-28       Impact factor: 3.535

4.  Insulin resistance in prostate cancer patients and predisposing them to acute ischemic heart disease.

Authors:  Udayan Ray; Sarbashri Bank; Madawa W Jayawardana; Jahar Bhowmik; Frank Redwig; Pradipta Jana; Suman Bhattacharya; Emili Manna; Subrata Kumar De; Smarajit Maiti; Philip Roberts-Thomson; Venkat Parameswaran; Asru K Sinha
Journal:  Biosci Rep       Date:  2019-07-29       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.